Indications
Our inhalation aerosol serves patients with chronic obstructive pulmonary disease (COPD) who still exhibit bronchospasm despite regular aerosol bronchodilator use, necessitating a second bronchodilator for effective relief.
Pharmacology
This inhalation aerosol combines Salbutamol (as Sulphate) and Ipratropium Bromide, offering an eco-friendly solution with its hydrofluoroalkane (HFA) formulation, free from ozone-depleting chlorofluorocarbon (CFC) propellants. By leveraging the synergistic action of Salbutamol and Ipratropium Bromide, it maximizes bronchodilation in COPD patients, targeting bronchospasm through dual mechanisms.
Dosage
Adults, including the elderly, are recommended two puffs of Salpium inhaler four times daily, with a maximum of 12 puffs in 24 hours, as directed by a physician.
Administration
Optimal inhaler usage is vital for effective treatment. Patients should follow precise steps to ensure proper medication delivery to the lungs, reducing the severity of asthma attacks and preventing complications.
Interaction
Our inhalation aerosol has been safely used alongside other medications for COPD treatment, including sympathomimetic bronchodilators and steroids. However, caution is advised when co-administering with other anticholinergic or sympathomimetic agents to mitigate the risk of adverse cardiovascular effects.
Contraindications
Patients with hypersensitivity to Soya-Lecithin or related food products like soybean and peanut, or to any other components of the drug product, atropine, or its derivatives should avoid using this inhalation aerosol.
Side Effects
Potential side effects may include mild tremor, headache, muscle cramps, and hypersensitivity reactions. These typically resolve with continuous treatment, but patients should seek medical advice if symptoms persist.
Pregnancy & Lactation
While Ipratropium Bromide is classified as pregnancy category B, caution is advised during pregnancy, as Salbutamol has shown teratogenic effects in animals. It should only be used if the benefits outweigh the risks. The excretion of components in human milk remains unknown, warranting cautious administration to nursing mothers.
Use in Special Populations
Patients with narrow-angle glaucoma, prostatic hypertrophy, bladder-neck obstruction, convulsive disorders, hyperthyroidism, or diabetes mellitus should use this inhalation aerosol with caution.
Overdose Effects
Overdose effects primarily relate to Salbutamol Sulphate and may include anginal pain, hypertension, hypokalemia, and tachycardia.
Therapeutic Class
Classified as combined bronchodilators, our inhalation aerosol offers comprehensive relief for respiratory conditions.
Storage Conditions
To maintain efficacy, store the pressurized canister in a cool, dry place, away from direct sunlight, heat, and children. Avoid puncturing or incinerating the canister, even when empty, and keep it away from eyes.
Reviews
There are no reviews yet.